Download PDF
Onkologische Welt 2012; 03(02): 63
DOI: 10.1055/s-0038-1630931
Gastro-Onkologie
Schattauer GmbH

Darmkrebs-Lebermetastasen und hepatozelluläres Karzinom: Die Bedeutung der Radioembolisation im Therapiekonzept

Angelika Bischof Dr. med
Further Information

Publication History

Publication Date:
02 February 2018 (online)

Also available at
    Permissions and Reprints

Die selektive interne Radiotherapie (SIRT) wird in einer Reihe von klinischen Studien bei Lebertumoren- und Metastasen untersucht. Die beste Datenlage liegt bisher für Metastasen kolorektaler Karzinome vor. Wesentlich weniger fortgeschritten ist die Evidenz für das hepatozelluläre Karzinom.

 

  • Literatur

  • 1 D’Avola D. et al. A retrospective comparative analysis of the effect of Y90-radioembolization on the survival of patients with unresectable hepatocellular carcinoma. Hepato-gastroenterology 2009; 56: 1683-1688.
    Google Scholar
  • 2 Gray B. et al. Randomized trial of SIR-spheres plus chemotherapy vs chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 2001; 12: 1711-1720.
    CrossrefGoogle Scholar
  • 3 Kennedy A. et al. Recommendations for radioembolizytion of hepatic malignancies using yttrium-90 microsphere brachytherapy: A consensus panel report from REBOC. Int J Radiation Oncology Biol Phys 2007; 68: 13-23.
    CrossrefGoogle Scholar
  • 4 Sharma R. et al. Radioembolization of liver metastases from colorectal cancer using yttrium-90 micorspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol 2007; 25: 1099-1106.
    CrossrefGoogle Scholar
  • 5 Van den Eynde M. et al. Inducing resectability of chemotherapy refractory colorectal liver metastasis by radioembolizytion with yttrium-90 microspheres. Clin nucl med 2008; 33: 697-699.
    CrossrefGoogle Scholar